Back
Novartis AG Quote, Financials, Valuation and Earnings
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Buy
73
NVSEF
Novartis AG
Last Price:
109.26
Seasonality Move:
4.4%
7 Day Trial
ALL ACCESS PASS
$
7
"If I Had To Start Again..." Expert Reveals #1 Investing Hack
In his latest free guide, Duffy reveals... click here to continue reading...Novartis AG Price Quote
$109.26
Novartis AG Key Stats
Buy
73
Novartis AG (NVSEF)
is a Buy
Day range:
$105.90 - $113.26
52-week range:
$90.24 - $123.55
Dividend yield:
3.41%
P/E ratio:
15.44
P/S ratio:
4.63
P/B ratio:
5.32%
Volume:
125.9K
Avg. volume:
4.8K
1-year change:
19.16%
Market cap:
$221.9B
Revenue:
$46.7B
EPS:
$7.81
How Much Does Novartis AG Make?
-
How Much Are Novartis AG's Sales Annually?
NVSEF Revenues are $46.7B -
How Much Profit Does Novartis AG's Make A Year?
NVSEF net income is $14.9B
Is Novartis AG Growing As A Company?
-
What Is Novartis AG's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.1% -
What Is Novartis AG's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.43%
Novartis AG Stock Price Performance
-
Did Novartis AG Stock Go Up Last Month?
Novartis AG share price went down by -0.97% last month -
Did NVSEF's Share Price Rise Over The Last Year?
NVSEF share price rose by 19.16% over the past 1 year
What Is Novartis AG 52-Week High & Low?
-
What Is Novartis AG’s 52-Week High Share Price?
Novartis AG has traded as high as $123.55 over the past 52 weeks -
What Is Novartis AG’s 52-Week Low Share Price?
Novartis AG has traded as low as $90.24 over the past 52 weeks
Novartis AG Price To Free Cash Flow
-
Is Novartis AG Stock Overvalued?
Novartis AG is trading at a price to free cash flow ratio of 19.30 -
Is Novartis AG Stock Undervalued?
Novartis AG EV to Free Cash Flow ratio is 20.56 -
What Is Novartis AG’s Price Earnings Growth Ratio?
NVSEF PEG ratio is 0.12 -
Is Novartis AG Trading At A Premium To Earnings?
Novartis AG EV to EBIT ratio is 20.40
Is It Risky To Buy Novartis AG?
-
How Much Debt Does Novartis AG Have?
Total long term debt quarterly is $27.2B -
How Much Cash Does Novartis AG Have?
Cash and short term investments quarterly total is $8.4B -
What Is Novartis AG’s Book Value Per Share?
Book value per share is 20.61
Is Novartis AG Cash Flow Positive?
-
What Is NVSEF Cash Flow From Operations?
Cash flow from operations (TTM) is $15.1B -
What Is Novartis AG’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$9.8B -
What Is Novartis AG’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$8.1B
Novartis AG Return On Invested Capital
-
Is Management Doing A Good Job?
NVSEF return on invested capital is 23.38% -
What Is Novartis AG Return On Assets?
ROA measures how assets are converting to revenues and is 15.69% -
What Is NVSEF Return On Equity?
ROE is a measure of profitability and is 37%
Novartis AG Earnings Date & Stock Price
-
What Is Novartis AG's Stock Price Today?
A single share of NVSEF can be purchased today for 109.26 -
What Is Novartis AG’s Stock Symbol?
Novartis AG trades on the otcm under the ticker symbol: NVSEF -
When Is Novartis AG’s Next Earnings Date?
The next quarterly earnings date for Novartis AG is scheduled on November 1, 2024 -
When Is NVSEF's next ex-dividend date?
Novartis AG's next ex-dividend date is March 7, 2024 -
How To Buy Novartis AG Stock?
You can buy Novartis AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Novartis AG Competitors
-
Who Are Novartis AG's Competitors?
Below is a list of companies who compete with Novartis AG or are related in some way:
Novartis AG Dividend Yield
-
What Is NVSEF Dividend Yield?
Novartis AG’s dividend yield currently is 3.41% -
What Is Novartis AG’s Payout Ratio?
Novartis AG’s payout ratio is 47.14% -
When Did Novartis AG Last Pay A Dividend?
The latest dividend pay date is November 1, 2024 -
What Is Novartis AG’s Dividend Per Share?
Novartis AG pays a dividend of $0.00 per share
Novartis AG Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 43.24% | 0% |
| Revenue: | 9.6% | 1.24% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 83.00 |
| Downside from Last Price: | -24.03% |